Drugs · acquisition-cost intelligence
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc· ingredient bacitracinAntibiotics· BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$4.79
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other bacitracin products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Antibiotic | $0.07565 | −$4.71 |
| Always Save Bacitracin Zinc | $0.09346 | −$4.69 |
| Antibiotic | $0.10680 | −$4.68 |
| Aerosoothe | $0.10787 | −$4.68 |
| Antibiotic, Pain and Scar | $0.12768 | −$4.66 |
| Bacitracin Zinc and Polymyxin B Sulfate | $2.75 | −$2.03 |
| Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone | $5.14 | +$0.35250 |
Medicare Part D coverage · CY2026
On 317 plan formularies · typical tier 3
Prior auth 0% · Step therapy 0% · Quantity limit 10% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.